Apple celebrates another court victory. Apple was recently sued by AliveCor, with the dispute involving the watch's irregular heartbeat detection. Silicon Valley-based startup AliveCor has accused the Cupertino giant of illegally monopolizing the U.S. heart rate monitoring app market for Apple Watch and violations of the Federal Antitrust Act and the California Unfair Competition Act.
You could be interested in
Although AliveCor's lawsuit was dismissed, the dispute is probably not over, as representatives are preparing an appeal. "AliveCor is deeply disappointed and strongly disagrees with the court's decision to dismiss our antitrust case, and we plan to appeal," was stated in the plaintiff's statement. In his statement Apple stated that today's court result confirms the fact that the actions Applu is not anti-competitive. In the lawsuit, AliveCor made an interesting claim, namely that Apple modified the heart rate sensing algorithm to prevent third parties from identifying irregular heartbeats and offering competing apps. For example, AliveCor has developed the KardiaBand, a wristband for Apple Watch capable of recording an electrocardiogram or ECG. If an appeal is filed, we will inform you about it. However, the dispute will most likely be heard at the first instance.ance will not end. For Apple is nevertheless positive miniat least for now, by monitoring your heart rate on Apple Watch he doesn't have to worry and therefore there is no risk of having to turn it off, just as he had to do recently in the US with blood oxygen sensing.